Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma : application to France, Germany, and the United Kingdom
M. F. Botteman; M. Meijboom; I. Foley; J. M. Stephens; Y. M. Chen...
| Year of publication: |
2011
|
|---|---|
| Authors: | Botteman, M. F. ; Meijboom, M. ; Foley, I. ; Stephens, J. M. ; Chen, Y. M. |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 12.2011, 6, p. 575-588
|
| Subject: | Deutschland | Germany | Großbritannien | United Kingdom | Frankreich | France | Patienten | Patients | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis |
| Extent: | graph. Darst. |
|---|---|
| Type of publication: | Article |
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10009376896